{
    "title": "107_hr5217",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Affordable Drugs Access Act''.\n\nSEC. 2. WAIVER REQUIREMENT FOR PERSONAL IMPORTATION OF PRESCRIPTION \n              DRUGS FROM CANADA.\n\n    (a) In General.--Chapter VIII of the Federal Food, Drug, and \nCosmetic Act (21 U.S.C. 381 et seq.) is amended by adding at the end \nthe following section:\n\n  ``waiver requirement for personal importation of prescription drugs \n                              from canada\n\n    ``Sec. 805. (a) In General.--With respect to the importation by \nindividuals of prescription drugs from Canada, the Secretary shall in \naccordance with this section establish by regulation a waiver of \nprohibitions under this Act that apply to the importation of drugs. \nSuch a waiver shall permit an individual to import into the United \nStates any prescription drug that--\n            ``(1) is imported from Canada for personal use by the \n        individual (not for resale);\n            ``(2) is approved by the Secretary under section 505, is \n        manufactured in an establishment registered with the Secretary \n        under section 510, and is not a controlled substance in \n        schedule I, II, or III under section 202(c) of the Controlled \n        Substances Act;\n            ``(3) is imported from a Canadian pharmacy that has \n        submitted to the Secretary a registration that identifies the \n        pharmacy and provides documentation that the pharmacy is \n        licensed in Canada;\n            ``(4) is imported in a quantity that does not (for that \n        instance of importation) exceed a 90-day supply;\n            ``(5) at the time of importation, is accompanied by a copy \n        of a valid prescription for the drug for the individual, issued \n        in the United States by a practitioner in accordance with \n        section 503(b), or is accompanied by documentation that \n        verifies the issuance of such a prescription for the \n        individual;\n            ``(6) is in the form of a final finished dosage; and\n            ``(7) is imported under such other conditions as the \n        Secretary determines to be necessary to ensure public safety.\n    ``(b) Study; Limitation on Waiver Requirement.--\n            ``(1) Study.--During the one-year period beginning on the \n        effective date of this section, the Secretary shall conduct a \n        study of prescription drugs imported from Canada under \n        subsection (a), and of prescription drugs that are imported \n        into the United States from other countries for personal use, \n        in order to determine the authenticity and quality of such \n        drugs.\n            ``(2) Limitation.--If through the study under paragraph (1) \n        the Secretary determines that drugs imported under subsection \n        (a) present a significant threat to the public health, the \n        following applies:\n                    ``(A) The Secretary may, in order to protect the \n                public health, establish one or more conditions for the \n                importation from Canada of prescription drugs for \n                personal use that are different than the conditions \n                described in such subsection, in which case any \n                conflicting condition described in such subsection \n                ceases to apply.\n                    ``(B) The Secretary may publish in the Federal \n                Register a statement that, pursuant to this section, \n                the Secretary has determined that waivers under this \n                section should be terminated in order to protect the \n                public health. Effective on the date on which such a \n                statement is so published, this section ceases to have \n                any legal effect.\n    ``(c) Authority Regarding Other Countries.--If through the study \nunder subsection (b)(1) the Secretary determines that drugs imported \nunder subsection (a) do not present a significant threat to the public \nhealth, or if under authority of subsection (b)(2)(A) the Secretary \nestablishes conditions in order to protect the public health, the \nSecretary may, in the case of such countries in addition to Canada as \nthe Secretary determines to be appropriate, establish by regulation a \nwaiver of prohibitions under this Act that apply to the importation of \ndrugs, under which waiver individuals are permitted to import into the \nUnited States prescription drugs that meet the conditions that apply \nunder subsection (a) (or under subsection (b)(2)(A), as the case may \nbe). Such regulations may establish country-specific conditions, as \ndetermined appropriate by the Secretary to protect the public health.\n    ``(d) Definition.--For purposes of this section, the term \n`prescription drug' means a drug that is subject to section 503(b).''.\n    (b) Assessment Regarding Additional Agency Inspectors at Ports of \nEntry.--The Secretary of Health and Human Services shall conduct an \nassessment to determine the additional number of inspectors that should \nbe added for the Food and Drug Administration at ports of entry into \nthe United States in order to provide adequate assurance that drugs \nimported into the United States meet the standards of the Federal Food, \nDrug, and Cosmetic Act. Not later than 180 days after the date of the \nenactment of this Act, the Secretary shall submit to the Congress a \nreport describing the findings of the assessment.\n\nSEC. 3. CONTROLLED SUBSTANCES; IMPORTATION WITHOUT VALID PRESCRIPTIONS.\n\n    Section 1006(a)(2) of the Controlled Substances Import and Export \nAct (21 U.S.C. 956(a)(2)) is amended by striking ``that exceeds 50 \ndosage units'' and all that follows and inserting the following: ``that \nexceeds 10 dosage units of the controlled substance, except that if the \nindividual is importing more than one such controlled substance into \nthe United States, the combined total number of dosage units of such \nsubstances imported by the individual may not exceed 10 dosage \nunits.''.\n\nSEC. 4. INTERNET SALES OF PRESCRIPTION DRUGS.\n\n    (a) In General.--Chapter 5 of the Federal Food, Drug, and Cosmetic \nAct (21 U.S.C. 351 et seq.) is amended by inserting after section 503A \nthe following section:\n\n``SEC. 503B. INTERNET SALES OF PRESCRIPTION DRUGS.\n\n    ``(a) Requirements Regarding Information on Internet Site.--\n            ``(1) In general.--A person may not dispense a prescription \n        drug pursuant to a sale of the drug by such person if--\n                    ``(A) the purchaser of the drug submitted the \n                purchase order for the drug, or conducted any other \n                part of the sales transaction for the drug, through an \n                Internet site; and\n                    ``(B) such site, or any other Internet site used by \n                such person for purposes of sales of a prescription \n                drug, fails to meet each of the requirements specified \n                in paragraph (2) (other than a site or pages on a site \n                that are not intended to be accessed by purchasers or \n                prospective purchasers).\n            ``(2) Requirements.--With respect to an Internet site, the \n        requirements referred to in subparagraph (B) of paragraph (1) \n        for a person to whom such paragraph applies are as follows:\n                    ``(A) Each page of the site shall include either \n                the following information or a link to a page that \n                provides the following information:\n                            ``(i) The name of such person; the address \n                        of the principal place of business of the \n                        person with respect to sales of prescription \n                        drugs through the Internet; and the telephone \n                        number for such place of business.\n                            ``(ii) Each State in which the person is \n                        authorized by law to dispense prescription \n                        drugs.\n                            ``(iii) The name of each individual who \n                        serves as a pharmacist for purposes of the \n                        site, and each State in which the individual is \n                        authorized by law to dispense prescription \n                        drugs.\n                            ``(iv) If the person provides for medical \n                        consultations through the site for purposes of \n                        providing prescriptions, the name of each \n                        individual who provides such consultations; \n                        each State in which the individual is licensed \n                        or otherwise authorized by law to provide such \n                        consultations; and the type or types of health \n                        professions for which the individual holds such \n                        licenses or other authorizations.\n                    ``(B) A link to which paragraph (1) applies shall \n                be clearly visible on the page involved, shall not be \n                of a size smaller than other links on the page (if \n                any), and shall include in the caption for the link the \n                words `licensing and contact information'.\n    ``(b) Internet Sales Without Appropriate Medical Relationships.--\n            ``(1) In general.--A person may not dispense a prescription \n        drug, or arrange the dispensing of such a drug, pursuant to a \n        sale of the drug if--\n                    ``(A) for purposes of such sale, the purchaser \n                communicated with the person through the Internet;\n                    ``(B) the patient for whom the drug was purchased \n                did not, when such communications began, have a \n                prescription for the drug;\n                    ``(C) pursuant to such communications, the person \n                provided for the involvement of a practitioner and the \n                practitioner issued a prescription for the drug that \n                was purchased;\n                    ``(D) the person knew, or had reason to know, that \n                the practitioner did not, when issuing the \n                prescription, have a qualifying medical relationship \n                with the patient; and\n                    ``(E)(i) the person received payment for the drug \n                from the purchaser; or\n                    ``(ii) in the case of arranging the dispensing of \n                the drug, the person received payment for doing so from \n                the person who dispensed the drug.\n        For purposes of subparagraph (E), payment is received if money \n        or other valuable consideration is received.\n            ``(2) Qualifying medical relationship.--\n                    ``(A) In general.--With respect to issuing a \n                prescription for a drug for a patient, a practitioner \n                has a qualifying medical relationship with the patient \n                for purposes of this section if at least one in-person \n                medical evaluation of the patient has been conducted by \n                the practitioner. This subparagraph and subparagraph \n                (B) may not be construed as having any applicability \n                beyond this section.\n                    ``(B) In-person medical evaluation.--A medical \n                evaluation by a practitioner is an in-person medical \n                evaluation for purposes of this section if the \n                practitioner is in the physical presence of the patient \n                as part of conducting the evaluation, without regard to \n                whether portions of the evaluation are conducted by \n                other health professionals.\n    ``(c) Actions by States.--\n            ``(1) In general.--Whenever an attorney general of any \n        State has reason to believe that the interests of the residents \n        of that State have been or are being threatened or adversely \n        affected because any person has engaged or is engaging in a \n        pattern or practice that violates section 301(l), the State may \n        bring a civil action on behalf of its residents in an \n        appropriate district court of the United States to enjoin such \n        practice, to enforce compliance with such section (including a \n        nationwide injunction), to obtain damages, restitution, or \n        other compensation on behalf of residents of such State, to \n        obtain reasonable attorneys fees and costs if the State \n        prevails in the civil action, or to obtain such further and \n        other relief as the court may deem appropriate.\n            ``(2) Notice.--The State shall serve prior written notice \n        of any civil action under paragraph (1) or (5)(B) upon the \n        Secretary and provide the Secretary with a copy of its \n        complaint, except that if it is not feasible for the State to \n        provide such prior notice, the State shall serve such notice \n        immediately upon instituting such action. Upon receiving a \n        notice respecting a civil action, the Secretary shall have the \n        right--\n                    ``(A) to intervene in such action;\n                    ``(B) upon so intervening, to be heard on all \n                matters arising therein; and\n                    ``(C) to file petitions for appeal.\n            ``(3) Construction.--For purposes of bringing any civil \n        action under paragraph (1), nothing in this chapter shall \n        prevent an attorney general of a State from exercising the \n        powers conferred on the attorney general by the laws of such \n        State to conduct investigations or to administer oaths or \n        affirmations or to compel the attendance of witnesses or the \n        production of documentary and other evidence.\n            ``(4) Venue; service of process.--Any civil action brought \n        under paragraph (1) in a district court of the United States \n        may be brought in the district in which the defendant is found, \n        is an inhabitant, or transacts business or wherever venue is \n        proper under section 1391 of title 28, United States Code. \n        Process in such an action may be served in any district in \n        which the defendant is an inhabitant or in which the defendant \n        may be found.\n            ``(5) Actions by other state officials.--\n                    ``(A) Nothing contained in this section shall \n                prohibit an authorized State official from proceeding \n                in State court on the basis of an alleged violation of \n                any civil or criminal statute of such State.\n                    ``(B) In addition to actions brought by an attorney \n                general of a State under paragraph (1), such an action \nmay be brought by officers of such State who are authorized by the \nState to bring actions in such State on behalf of its residents.\n    ``(d) Definitions.--\n            ``(1) Internet-related definitions.--For purposes of this \n        section:\n                    ``(A) The term `Internet' means collectively the \n                myriad of computer and telecommunications facilities, \n                including equipment and operating software, which \n                comprise the interconnected world-wide network of \n                networks that employ the transmission control protocol/\n                internet protocol, or any predecessor or successor \n                protocols to such protocol, to communicate information \n                of all kinds by wire or radio.\n                    ``(B) The term `link', with respect to the \n                Internet, means one or more letters, words, numbers, \n                symbols, or graphic items that appear on a page of an \n                Internet site for the purpose of serving, when \n                activated, as a method for executing an electronic \n                command--\n                            ``(i) to move from viewing one portion of a \n                        page on such site to another portion of the \n                        page;\n                            ``(ii) to move from viewing one page on \n                        such site to another page on such site; or\n                            ``(iii) to move from viewing a page on one \n                        Internet site to a page on another Internet \n                        site.\n                    ``(C) The term `page', with respect to the \n                Internet, means a document or other file accessed at an \n                Internet site.\n                    ``(D)(i) The terms `site' and `address', with \n                respect to the Internet, mean a specific location on \n                the Internet that is determined by Internet Protocol \n                numbers. Such term includes the domain name, if any.\n                    ``(ii) The term `domain name' means a method of \n                representing an Internet address without direct \n                reference to the Internet Protocol numbers for the \n                address, including methods that use designations such \n                as `.com', `.edu', `.gov', `.net', or `.org'.\n                    ``(iii) The term `Internet Protocol numbers' \n                includes any successor protocol for determining a \n                specific location on the Internet.\n            ``(2) Other definitions.--For purposes of this section:\n                    ``(A) The term `practitioner', with respect to the \n                issuance of a prescription for a drug for a patient, \n                means--\n                            ``(i) an individual authorized by law to \n                        administer the drug; or\n                            ``(ii) an individual who is not so \n                        authorized but represents himself or herself as \n                        an individual who is so authorized.\n                    ``(B) The term `prescription drug' means a drug \n                that is subject to section 503(b).\n                    ``(C) The term `qualifying medical relationship', \n                with respect to a practitioner and a patient, has the \n                meaning indicated for such term in subsection (b).''.\n    (b) Inclusion as Prohibited Act.--Section 301 of the Federal Food, \nDrug, and Cosmetic Act (21 U.S.C. 331) is amended by inserting after \nparagraph (k) the following:\n    ``(l) The dispensing of a prescription drug in violation of section \n503B, or arranging for the dispensing of such a drug in violation of \nsuch section.''.\n    (c) Internet Sales of Prescription Drugs; Consideration by \nSecretary of Practices and Procedures for Certification of Legitimate \nBusinesses.--In carrying out section 503B of the Federal Food, Drug, \nand Cosmetic Act (as added by subsection (a) of this section), the \nSecretary of Health and Human Services shall take into consideration \nthe practices and procedures of public or private entities that certify \nthat businesses selling prescription drugs through Internet sites are \nlegitimate businesses, including practices and procedures regarding \ndisclosure formats and verification programs.\n    (d) Effective Date.--The amendments made by subsections (a) and (b) \ntake effect upon the expiration of the 60-day period beginning on the \ndate of the enactment of this Act, without regard to whether a final \nrule to implement such amendments has been promulgated by the Secretary \nof Health and Human Services under section 701(a) of the Federal Food, \nDrug, and Cosmetic Act. The preceding sentence may not be construed as \naffecting the authority of such Secretary to promulgate such a final \nrule."
}